2 Minute Medicine

No Result

View All Result

No products in the cart.

Home Tag gastroesophageal adenocarcinoma

Tag: gastroesophageal adenocarcinoma

#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with HER2-positive gastro-esophageal cancer

#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with HER2-positive gastro-esophageal cancer

byAlisha Yiand1 others

January 18, 2024

1. Progression-free survival was significantly greater among patients in the pembrolizumab group compared to placebo (10.0 vs. 8.1 months). 2. ...

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Pembrolizumab enhances progression-free survival in patients with HER2-positive gastro-esophageal cancer

byNeel Mistryand1 others

January 10, 2024

1. Progression-free survival was significantly greater among patients in the pembrolizumab group compared to placebo (10.0 vs. 8.1 months). 2. ...

Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria

Zolbetuximab improves survival in patients with advanced or metastatic gastric adenocarcinoma

byNeel Mistryand1 others

1. Median progression-free survival in zolbetuximab group was greater than in the placebo group (10.6 months vs. 8.7 months). 2. ...

#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage

#VisualAbstract: FOLFOX in combination with nivolumab and trastuzumab improves survival in metastatic ERBB2⁺ esophagogastric adenocarcinoma

Click to read this study in JAMA Oncology.

#VisualAbstract: Melanoma survival outcomes have improved between 2003 and 2019 amidst increasing incidence rates

#VisualAbstract: Perioperative oxiplatin with S-1 significantly improves survival in patients with advanced gastric cancer or gastroesophageal adenocarcinoma undergoing D2 gastrectomy

September 23, 2021

Click to read the study in The Lancet Oncology.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

No Result

View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.